RaySearch Laboratories AB (publ)
STO:RAY B

Watchlist Manager
RaySearch Laboratories AB (publ) Logo
RaySearch Laboratories AB (publ)
STO:RAY B
Watchlist
Price: 204 SEK -0.49% Market Closed
Market Cap: 7B SEK
Have any thoughts about
RaySearch Laboratories AB (publ)?
Write Note

Gross Margin
RaySearch Laboratories AB (publ)

91.1%
Current
90%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
91.1%
=
Gross Profit
1.1B
/
Revenue
1.2B

Gross Margin Across Competitors

Country SE
Market Cap 7B SEK
Gross Margin
91%
Country US
Market Cap 36.3B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.6B AUD
Gross Margin
100%
Country US
Market Cap 10.8B USD
Gross Margin
90%
Country US
Market Cap 6.3B USD
Gross Margin
67%
Country JP
Market Cap 927.2B JPY
Gross Margin
58%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 52.8B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.7B CNY
Gross Margin
43%
No Stocks Found

RaySearch Laboratories AB (publ)
Glance View

Market Cap
7B SEK
Industry
Health Care

RaySearch Laboratories AB is a medical technology company, which engages in the development of software solutions for improved radiation therapy of cancer. The company is headquartered in Stockholm, Stockholm. The company markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. As of December 31, 2011, 15 of the Company’s products were launched, including the software platform ORBIT (optimization of radiation therapy beams by iterative technique), which is available in its main products, and is a non-clinical system which functions as a research and development environment. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.

RAY B Intrinsic Value
219.97 SEK
Undervaluation 7%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
91.1%
=
Gross Profit
1.1B
/
Revenue
1.2B
What is the Gross Margin of RaySearch Laboratories AB (publ)?

Based on RaySearch Laboratories AB (publ)'s most recent financial statements, the company has Gross Margin of 91.1%.